[1]常文婧 王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J].心血管病学进展,2019,(8):1115-1118.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
　CHANG Wenjin,WANG Lina.Role of Hippo Pathway in Heart Development,Regeneration and Disease[J].Advances in Cardiovascular Diseases,2019,(8):1115-1118.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
点击复制

Hippo通路在心脏发育、再生和疾病中的作用()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年8期
页码:
1115-1118
栏目:
出版日期:
2019-11-25

文章信息/Info

Title:
Role of Hippo Pathway in Heart Development,Regeneration and Disease
作者:
常文婧 王丽娜
(哈尔滨医科大学基础医学院病理生理学教研室,黑龙江 哈尔滨 150086)
Author(s):
CHANG Wenjin; WANG Lina
(Department of Pathophysiology , Basic School of Medicine, Harbin Medical University, Harbin 150086, Heilongjiang, China)
关键词:
Hippo通路; 心脏发育; 再生; 心肌梗死
Keywords:
Hippo pathway;  Heart development;  Regeneration;  Myocardial infarction
DOI:
10.16806/j.cnki.issn.1004-3934.2019.08.011
摘要:
由于人类的心脏缺乏自我修复的能力，故心肌梗死等损伤后心肌细胞的丢失可导致心力衰竭和死亡。因此，努力提高心肌细胞自我修复能力是具有前景的治疗策略。Hippo通路作为器官大小和生长的调节因子，是一种进化和功能上十分保守的通路，其在细胞增殖、凋亡和分化中起重要作用。靶向Hippo通路可为心肌梗死后心肌的修复和再生提供新的治疗思路。此篇综述总结了近十年的发现，揭示Hippo通路在心脏发育、再生和疾病中的作用，并探讨其在心脏疾病诊断和治疗的可能策略。
Abstract:
The human heart lacks the ability to repair itself, so the loss of myocardial cells after injury such as myocardial infarction can lead to heart failure and death.Therefore,improving cardiomyocyte viability remain attractive therapeutic strategies. Hippo pathway,as a regulator of organ size and growth,is an evolutionarily and functionally conservative pathway, which plays an important role in cell proliferation,apoptosis and differentiation.Targeting the Hippo pathway provides a new therapeutic approach for cardiac repair and regeneration for myocardialinfarction.In this review,we summarize the findings of the past decade,reveal the role of Hippo pathway in heart development,regeneration and disease,and explore its possible strategies in the diagnosis and treatment of heart disease

参考文献/References:

[1] Buttitta LA,Edgar BA. How size is controlled:from Hippos to Yorkies[J]. Nat Cell Biol,2007,9(11):1225-1227.

[2] Zhou Q,Li L,Zhao B,et al. The hippo pathway in heart development,regeneration,and diseases[J]. Circ Res,2015,116(8):1431-1447.

[3] Del Re DP. Hippo signaling in the heart-non-canonical pathways impact growth,survival and function[J]. Circ J,2016,80(7):1504-1510.

[4] Xiao Y,Leach J,Wang J,et al. Hippo/YAP signaling in cardiac development and regeneration[J]. Curr Treat Options Cardiovasc Med ,2016,18(6):38.

[5] Gibault F,Corvaisier M,Bailly F,et al. Non-photoinduced biological properties of verteporfin[J]. Curr Med Chem,2016,23(11):1171-1184.

[6] Yu FX,Zhao B,Guan KL . Hippo pathway in organ size control,tissue homeostasis,and cancer[J]. Cell,2015,163(4):811-828.

[7] Meng Z,Moroishi T,Guan KL . Mechanisms of Hippo pathway regulation[J]. Genes Dev,2016,30(1):1-17.

[8] Dong J,Feldmann G,Huang J,et al. Elucidation of a universal size-control mechanism in Drosophila and mammals[J]. Cell,2007,130(6):1120-1133.

[9] von Gise A,Lin Z,Schlegelmilch K,et al. YAP1,the nuclear target of Hippo signaling,stimulates heart growth through cardiomyocyte proliferation but not hypertrophy[J]. Proc Natl Acad Sci U S A,2012,109(7):2394-2399.

[10] Lin Z,Guo H,Cao Y,et al. acetylation of VGLL4 regulates Hippo-YAP signaling and postnatal cardiac growth[J]. Dev Cell,2016,39(4):466-479.

[11] Xin M,Kim Y,Sutherland LB,et al. Regulation of insulin-like growth factor signaling by YAP governs cardiomyocyte proliferation and embryonic heart size[J]. Sci Signal ,2011,4(196):ra70.

[12] Xin M,Kim Y,Sutherland LB,et al. Hippo pathway effector YAP promotes cardiac regeneration[J]. Proc Natl Acad Sci U S A ,2013,110(34):13839-13844.

[13] Senyo SE,Steinhauser ML,Pizzimenti CL,et al. Mammalian heart renewal by pre-existing cardiomyocytes[J]. Nature,2013,493(7432):433-436.

[14] Lin Z,Zhou P,von Gise A,et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival[J]. Circ Res,2015,116(1):35-45.

[15] Tian Y,Liu Y,Wang T,et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice[J]. Sci Transl Med,2015,7(279):279ra38.

[16] Tao G,Kahr PC,Morikawa Y,et al. Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury[J]. Nature,2016,534(7605):119-123.

[17] Yamamoto S,Yang G,Zablocki D,et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy[J]. J Clin Invest,2003,111(10):1463-1474.

[18] Odashima M,Usui S,Takagi H,et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction[J]. Circul R es,2007,100(9):1344-1352.

[19] Zhang N,Bai H,David KK,et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals[J]. Dev Cell,2010,19(1):27-38.

[20] Lavado A,He Y,Pare J,et al. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting YAP/TAZ transcriptional coactivators[J]. Development ,2013,140(16):3323-3334.

[21] del Re DP,Matsuda T,Zhai P,et al. Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL[J]. Mol Cell,2014,54(4):639-650.

[22] Matsuda T,Zhai P,Sciarretta S,et al. NF2 activates Hippo signaling and promotes ischemia/reperfusion injury in the heart[J]. Circ Res,2016,119(5):596-606.

[23] Nakamura M,Zhai P,Del Re DP,et al. Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury[J]. JCI Insight,2016,1(5).pii:e86217.

[24] Zi M,Maqsood A,Prehar S,et al. The mammalian Ste20-like kinase 2(Mst2) modulates stress-induced cardiac hypertrophy[J]. J Biol Chem,2014,289(35):24275-24288.

[25] Yang Y,del Re DP,Nakano N,et al. miR-206 mediates YAP-induced cardiac hypertrophy and survival[J]. Circ Res,2015,117(10):891-904.

[26] Wang P,Mao B,Luo W,et al. The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy[J]. Basic Res Cardiol,2014,109(5):435.

[27] 肖丹丹,常文光,法鸿鸽,等. Parkin介导的线粒体自噬:调控心血管疾病的新机制[J]. 心血管病学进展,2019,40(1):1004-3934.

[28] Maejima Y,Kyoi S,Zhai P,et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2[J]. Nat Med,2013,19(11):1478-1488.

[29] Leach JP,Heallen T,Zhang M,et al. Hippo pathway deficiency reverses systolic heart failure after infarction[J]. Nature,2017,550(7675):260-264.

[30] Lin Z,von Gise A,Zhou P,et al. Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model[J]. Circ Res,2014,115(3):354-363.

相似文献/References:

[1]曾庆跃 徐娇 施奕 牟钘雨 李双庆.心脏发育关键转录因子与心肌细胞直接重编程的研究进展[J].心血管病学进展,2023,(10):934.[doi:10.16806/j.cnki.issn.1004-3934.2023.10.016]
　ZENG QingyueXU JiaoSHI YiMOU XingyuLI Shuangqing.Transcription Factors for Cardiac Development and Direct Cardiac Reprogramming[J].Advances in Cardiovascular Diseases,2023,(8):934.[doi:10.16806/j.cnki.issn.1004-3934.2023.10.016]

备注/Memo

备注/Memo:
基金项目：黑龙江省自然科学基金（H2016015）
更新日期/Last Update: 2020-01-20